- Home
- ECVT vs TSHA Comparison
ECVT vs TSHA Comparison
Compare ECVT & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECVT
- TSHA
- Stock Information
- Founded
- ECVT 1935
- TSHA 2019
- Country
- ECVT United States
- TSHA United States
- Employees
- ECVT N/A
- TSHA N/A
- Industry
- ECVT Major Chemicals
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- ECVT Industrials
- TSHA Health Care
- Exchange
- ECVT Nasdaq
- TSHA Nasdaq
- Market Cap
- ECVT 874.6M
- TSHA 728.4M
- IPO Year
- ECVT 2017
- TSHA 2020
- Fundamental
- Price
- ECVT $8.68
- TSHA $2.68
- Analyst Decision
- ECVT Strong Buy
- TSHA Strong Buy
- Analyst Count
- ECVT 4
- TSHA 6
- Target Price
- ECVT $10.00
- TSHA $8.17
- AVG Volume (30 Days)
- ECVT 1.8M
- TSHA 2.9M
- Earning Date
- ECVT 07-31-2025
- TSHA 08-11-2025
- Dividend Yield
- ECVT N/A
- TSHA N/A
- EPS Growth
- ECVT N/A
- TSHA N/A
- EPS
- ECVT N/A
- TSHA N/A
- Revenue
- ECVT $706,153,000.00
- TSHA $7,224,000.00
- Revenue This Year
- ECVT $14.91
- TSHA N/A
- Revenue Next Year
- ECVT $4.99
- TSHA N/A
- P/E Ratio
- ECVT N/A
- TSHA N/A
- Revenue Growth
- ECVT 2.23
- TSHA N/A
- 52 Week Low
- ECVT $5.24
- TSHA $1.05
- 52 Week High
- ECVT $9.92
- TSHA $3.31
- Technical
- Relative Strength Index (RSI)
- ECVT 60.25
- TSHA 59.68
- Support Level
- ECVT $8.39
- TSHA $2.33
- Resistance Level
- ECVT $8.90
- TSHA $2.51
- Average True Range (ATR)
- ECVT 0.31
- TSHA 0.14
- MACD
- ECVT 0.02
- TSHA 0.02
- Stochastic Oscillator
- ECVT 85.43
- TSHA 90.43
About ECVT Ecovyst Inc.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: (1) Ecoservices and (2) Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.